<p>Dr. Ryan Neely is the VP of Science &amp; Research at Elemind, a company developing neurotechnology that will induce drug-like effects on the brain without any chemicals or side effects. Dr. Neely studied neuroscience at Harvard and the University of California, Berkeley, where he developed new technologies for brain-machine interfaces. After earning his doctorate, he helped start a company building miniaturized, wireless neural interfaces to detect and treat disease. Later, he worked on AI-driven techniques to discover new cancer drugs by growing patients’ 3D tumors in the lab. More recently, Dr. Neely has turned his attention to leveraging non-invasive neurotechnology to improve the quantity and quality of sleep. Dr. Neely is an author of 13 scientific publications and an inventor of 10 patents.</p>


Ryan Neely, PhD